Report on main progress of acute lymphoblastic leukemia in the 54th ASH annual meeting / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 706-708, 2012.
Artigo
em Chinês
| WPRIM
| ID: wpr-474422
ABSTRACT
Acute lymphoblastic leukemia (ALL) is a heterogeneous disease affected by patient' s age,immunologic subtype,genetic and molecular features.In the 54th ASH annual meeting,lots of new discoveries about the biology,prognosis and treatment of ALL were reported.Here highlights of genomic profiling,new targeted therapy and hematopoietic stem cell transplantation for ALL presented in this meeting are introduced.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Journal of Leukemia & Lymphoma
Ano de publicação:
2012
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS